Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSN
5751
DELISTED
Mersana Therapeutics
MRSN
| $42K | ﹤0.01% |
515
+306
| +146% | +$44.8K |
|
5752
MaxCyte
MXCT
$136M
| $42K | ﹤0.01% |
9,162
+4,091
| +81% | +$18.8K |
|
|
VOXR
5753
Vox Royalty Corp
VOXR
$359M
| $42K | ﹤0.01% |
17,588
+588
| +3% | +$1.62K |
|
|
TE
5754
T1 Energy
TE
$1.51B
| $42K | ﹤0.01% |
4,463
-4,197
| -48% | -$31.5K |
|
|
NPKI
5755
NPK International
NPKI
$1.21B
| $42K | ﹤0.01% |
8,051
+3,224
| +67% | +$13.4K |
|
|
CNSL
5756
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $42K | ﹤0.01% |
10,968
+4,579
| +72% | +$16.5K |
|
5757
ARKO Corp
ARKO
$544M
| $41K | ﹤0.01% |
5,116
-22,271
| -81% | -$177K |
|
5758
Smartbird Inc
BIRD
$30.1M
| $41K | ﹤0.01% |
1,585
-135
| -8% | -$3.37K |
|
5759
Compass Therapeutics
CMPX
$405M
| $41K | ﹤0.01% |
12,750
+11,793
| +1,232% | +$37K |
|
5760
Dakota Gold
DC
$836M
| $41K | ﹤0.01% |
14,085
+11,150
| +380% | +$36.7K |
|
5761
Heritage Insurance Holdings
HRTG
$1.01B
| $41K | ﹤0.01% |
10,594
+9,531
| +897% | +$38.2K |
|
|
JHS
5762
John Hancock Income Securities Trust
JHS
$128M
| $41K | ﹤0.01% |
3,772
+150
| +4% | +$1.63K |
|
5763
The Joint Corp
JYNT
$120M
| $41K | ﹤0.01% |
3,014
+61
| +2% | +$896 |
|
5764
Pulmonx
LUNG
$104M
| $41K | ﹤0.01% |
3,092
+1,175
| +61% | +$14.4K |
|
|
DSEY
5765
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $41K | ﹤0.01% |
4,885
+512
| +12% | +$4.23K |
|
|
TCFC
5766
DELISTED
The Community Financial Corporation Common Stock
TCFC
| $41K | ﹤0.01% |
1,479
+726
| +96% | +$20.6K |
|
5767
Alkami Technology
ALKT
$2.21B
| $40K | ﹤0.01% |
2,454
+425
| +21% | +$5.86K |
|
|
CCIF
5768
Carlyle Credit Income Fund
CCIF
$59.8M
| $40K | ﹤0.01% |
4,000
| – | – |
|
5769
ClearPoint Neuro
CLPT
$468M
| $40K | ﹤0.01% |
5,461
+5,287
| +3,039% | +$45K |
|
5770
CaliberCos
CWD
$4.64M
| $40K | ﹤0.01% |
+1,049
| New | +$59.6K |
|
5771
eHealth
EHTH
$39.1M
| $40K | ﹤0.01% |
4,854
+1,243
| +34% | +$9.94K |
|
5772
Edgewise Therapeutics
EWTX
$4.8B
| $40K | ﹤0.01% |
5,164
+2,339
| +83% | +$19.7K |
|
|
KALV
5773
DELISTED
KalVista Pharmaceuticals
KALV
| $40K | ﹤0.01% |
4,492
+3,113
| +226% | +$28.7K |
|
5774
Liquidia Corp
LQDA
$6.66B
| $40K | ﹤0.01% |
5,060
+864
| +21% | +$6.71K |
|
|
MGF
5775
Aberdeen Government Markets Income Fund
MGF
$92.6M
| $40K | ﹤0.01% |
12,462
-4,793
| -28% | -$15.7K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 675 new, 3,796 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 675 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.